Lataa...
Genome-wide association study identifies SESTD1 as a novel risk gene for lithium-responsive bipolar disorder
Lithium is the mainstay prophylactic treatment for bipolar disorder (BD), but treatment response varies considerably across individuals. Patients who respond well to lithium treatment might represent a relatively homogeneous subtype of this genetically and phenotypically diverse disorder. Here, we p...
Tallennettuna:
| Julkaisussa: | Mol Psychiatry |
|---|---|
| Päätekijät: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Nature Publishing Group
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4995544/ https://ncbi.nlm.nih.gov/pubmed/26503763 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mp.2015.165 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|